Brief: 9 Meters Biopharma Collaborates With Celiac Disease Foundation To Support Clinical Trial Enrollment In Phase 3 Trial Of Larazotide In Celiac Disease
12/04/2021 12:41
April 12 (Reuters) - 9 Meters Biopharma Inc NMTR.O :
* 9 METERS BIOPHARMA - COLLABORATE WITH CELIAC DISEASE
FOUNDATION
TO SUPPORT CLINICAL TRIAL ENROLLMENT IN PHASE 3 TRIAL OF
LARAZOTIDE IN CELIAC DISEASE
Source: [ID: https://bit.ly/3d8jm2E]
Further company coverage: NMTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection